3 completed, 1 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Albutein 5%: new trials by email Literature Review of Albutein 5% trials Research Report on Albutein 5%
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% SMT + PE-A 5%, Standard Medical Treatment - Acute-On-Chronic Liver Failure | Phase 3 | Terminated | Instituto Grifols, S.A. | 274 | 2019-06-17 | 2026-06-04 |
| Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis Albutein 5%, Plasma Exchange - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | Grifols Therapeutics LLC | 12 | 2016-08-29 | 2021-05-05 |
| Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis Albumin - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | Instituto Grifols, S.A. | 13 | 2014-11-01 | 2020-06-16 |
| Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid Albutein 5%, Control - Alzheimer's Disease | Phase 2 | Completed | Instituto Grifols, S.A. | 42 | 2007-07-01 | 2016-06-14 |
Amyotrophic Lateral Sclerosis (2) · Acute-On-Chronic Liver Failure (1) · Alzheimer Disease (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Mental Disorders (1) · Plaque, Amyloid (1)
Instituto Grifols, S.A. (3) · Grifols Therapeutics LLC (1)
Spain (3) · United States (3) · Austria (1) · Belgium (1) · France (1) · Germany (1) · Italy (1) · Portugal (1) · United Kingdom (1)
Antonio Paez (1) · Merce Boada, MD (1)